Search Results - "Fisniku, Leonora"

Gray matter atrophy is related to long-term disability in multiple sclerosis by Fisniku, Leonora K., Chard, Declan T., Jackson, Jonathan S., Anderson, Valerie M., Altmann, Daniel R., Miszkiel, Katherine A., Thompson, Alan J., Miller, David H.

“…Objective To determine the relation of gray matter (GM) and white matter (WM) brain volumes, and WM lesion load, with clinical outcomes 20 years after first…”
Get full text

Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosis by Barritt, Andrew W, Das, Esther, Morley, Nadine, Seymour, Matthew, Saha, Romi, Vera, Jaime, Vundavalli, Sriram, Dizdarevic, Sabina, Nicholas, Richard, Berger, Joseph R, Fisniku, Leonora K

“…A 62-year-old man with relapsing-remitting multiple sclerosis developed progressive multifocal leukencephalopathy (PML) after 6 years on fingolimod. The…”
Get full text

Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD? by Chen, Bo, Gomez‐Figueroa, Enrique, Redenbaugh, Vyanka, Francis, Anna, Satukijchai, Chanjira, Wu, Yan, Messina, Silvia, Sa, Mario, Woodhall, Mark, Robertson, Neil P., Lim, Ming, Wassmer, Evangeline, Kneen, Rachel, Huda, Saif, Blain, Camilla, Halfpenny, Christopher, Hemingway, Cheryl, O'Sullivan, Eoin, Hobart, Jeremy, Fisniku, Leonora K., Martin, Roswell J., Dobson, Ruth, Cooper, Sarah A., Williams, Victoria, Waters, Patrick, Chen, John J., Pittock, Sean J., Ramdas, Sithara, Leite, Maria Isabel, Flanagan, Eoin P., Geraldes, Ruth, Palace, Jacqueline

“…Objective Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) can be monophasic or relapsing, with early relapse being a feature. However,…”
Get full text

Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom by Satukijchai, Chanjira, Mariano, Romina, Messina, Silvia, Sa, Mario, Woodhall, Mark R, Robertson, Neil P, Ming, Lim, Wassmer, Evangeline, Kneen, Rachel, Huda, Saif, Jacob, Anu, Blain, Camilla, Halfpenny, Christopher, Hemingway, Cheryl, O'Sullivan, Eoin, Hobart, Jeremy, Fisniku, Leonora K, Martin, Roswell, Dopson, Ruth, Cooper, Sarah A, Williams, Victoria, Waters, Patrick J, Ramdas, Sithara, Leite, Maria Isabel, Palace, Jacqueline

“…Longer-term outcomes and risk factors associated with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are not well established. To…”
Get full text

MS care: integrating advanced therapies and holistic management by Giovannoni, Gavin, Ford, Helen L, Schmierer, Klaus, Middleton, Rod, Stennett, Andrea M, Pomeroy, Ian, Fisniku, Leonora, Scalfari, Antonio, Bannon, Colin, Stross, Ruth, Hughes, Sarah, Williams, Adam, Josephs, Samantha, Peel, Charlie, Straukiene, Agne

“…Lifestyle and environmental factors are key determinants in disease causality and progression in neurological conditions, including multiple sclerosis (MS)…”
Get full text

Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination by Francis, Anna G., Elhadd, Kariem, Camera, Valentina, Ferreira dos Santos, Monica, Rocchi, Chiara, Adib-Samii, Poneh, Athwal, Bal, Attfield, Kathrine, Barritt, Andrew, Craner, Matthew, Fisniku, Leonora, Iversen, Astrid K.N., Leach, Oliver, Matthews, Lucy, Redmond, Ian, O'Riordan, Jonathan, Scalfari, Antonio, Tanasescu, Radu, Wren, Damian, Huda, Saif, Leite, Maria Isabel, Fugger, Lars, Palace, Jacqueline

“…Acute inflammatory CNS diseases include neuromyelitis optica spectrum disorders (NMOSDs) and myelin oligodendrocyte glycoprotein antibody-associated disease…”
Get full text

056  OCT screening prior to starting fingolimod: is it truly justified? by Fisniku, Leonora, Tageldin, Amr

“…Background and Aim Fingolimod, an oral immunomodulating drug is used in the management of relaps- ing-remitting MS (RRMS)-patients. Fingolimod-related macular…”
Get full text

TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis by Papadopoulos, Konstantinos, Tozer, Daniel J, Fisniku, Leonora, Altmann, Daniel R, Davies, Gerard, Rashid, Waqar, Thompson, Alan J, Miller, David H, Chard, Declan T

“…The pathological effects of multiple sclerosis are not confined to lesions; tissues that appear normal on conventional magnetic resonance imaging scans are…”
Get full text

072  The oblique path of a transverse lesion by Kesserwani, Jad, Cooper, Rebecca, Wickremaratchi, Mirdhu, Palace, Jaqueline, Fisniku, Leonora

“…A 38-year-old man presented in September 2016 with left hand numbness which progressed over 2 days to disabling weakness of his left arm and leg. He initially…”
Get full text

006  Secondary amenorrhea related to natalizumab by Obeng, Laurenda, Brown, Heather, Wheately, Trevor, Good, Catriona, Fisniku, Leonora

“…BackgroundAdverse events are inevitable for many pharmacological interventions, including disease modifying treatment (DMT) in Multiple Sclerosis (MS)…”
Get full text

005  Infusion associated reactions in ocrelizumab-treated multiple sclerosis patients by Das, Esther, Bewick, Claire, Collins, Justine, Nash, Cynthia, Fisniku, Leonora

“…Background and aimsInfusion-associated-reactions (IARs) are a common side effect (SE) of Ocrelizumab, a disease modifying therapy (DMT) licensed for treatment…”
Get full text

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study by Varatharaj, Aravinthan, Thomas, Naomi, Ellul, Mark A, Davies, Nicholas W S, Pollak, Thomas A, Tenorio, Elizabeth L, Sultan, Mustafa, Easton, Ava, Zandi, Michael, Coles, Jonathan P, Manji, Hadi, Al-Shahi Salman, Rustam, Menon, David K, Nicholson, Timothy R, Benjamin, Laura A, Carson, Alan, Turner, Martin R, Solomon, Tom, Kneen, Rachel, Pett, Sarah L, Galea, Ian, Thomas, Rhys H, Michael, Benedict D, Allen, Claire, Archibald, Neil, Arkell, James, Arthur-Farraj, Peter, Baker, Mark, Ball, Harriet, Bradley-Barker, Verity, Brown, Zoe, Bruno, Stefania, Carey, Lois, Carswell, Christopher, Chakrabarti, Annie, Choulerton, James, Daher, Mazen, Davies, Ruth, Di Marco Barros, Rafael, Dima, Sofia, Dunley, Rachel, Dutta, Dipankar, Everitt, Alex, Fady, Joseph, Fearon, Patricia, Fisniku, Leonora, Gbinigie, Ivie, Gemski, Alan, Gillies, Emma, Gkrania-Klotsas, Effrossyni, Hamdalla, Hisham, Hubbett, Jack, Hunter, Neil, Ispoglou, Sissi, Jha, Ashwani, Joussi, Ramzi, Khalifeh, Hind, Kooij, Sander, Kumar, Guru, Kyaw, Sandar, Li, Lucia, Littleton, Edward, Macleod, Mary Joan, Madigan, Barbara, Mahadasa, Vikram, Manoharan, Manonmani, Marigold, Richard, Marks, Isaac, Matthews, Paul, Mccormick, Michael, Mcinnes, Caroline, Metastasio, Antonio, Milburn-McNulty, Philip, Mitchell, Duncan, Morgans, Clare, Morris, Huw, Morrow, Jasper, Mubarak Mohamed, Ahmed, Murphy, Louis, Namushi, Robert, Newman, Edward, Phillips, Wendy, Pinto, Ashwin, Price, David Ashley, Proschel, Harald, Ramsey, Deborah, Ross Russell, Amy, Samarasekera, Neshika, Sawcer, Stephen, Sayed, Walee, Sekaran, Lakshmanan, Serra-Mestres, Jordi, Snowdon, Victoria, Strike, Gayle, Vrana, Mark, Wharton, Chris, Wiblin, Lou, Boubriak, Iryna, Herman, Katie, Plant, Gordon

“…Concerns regarding potential neurological complications of COVID-19 are being increasingly reported, primarily in small series. Larger studies have been…”
Get full text

201 Alemtuzumab related HPV infection and cervical dysplasia: real world data by Ruffer, Giles, Koniotes, Anna, Warren, Catherine, Bozzali, Marco, Fisniku, Leonora

“…BackgroundAlemtuzumab a disease-modifying-therapy for relapsing-remitting Multiple Sclerosis (RRMS) increases the risk of Human Papilloma Virus (HPV) and…”
Get full text

Po120 CMT1A and co-existing primary progressive multiple sclerosis by Cooper, Rebecca, Barritt, Andrew, Hughes, Paul, Fisniku, Leonora

“…A 56-year-old lady presented with a 3 year history of slowly worsening mobility and balance, spasms, and sphincter dysfunction. At 46 she received a…”
Get full text

215 Demographic, clinical and paraclinical features in a subgroup of patients with NMOSD by Wegehaupt, Thomas, Vundavalli, Sriram, Cooper, Sarah, Leite, Maria, Palace, Jacqueline, Fisniku, Leonora

“…BackgroundNeuromyelitis optica spectrum disorder (NMOSD) is an autoimmune, inflammatory condition more commonly distinguished from multiple sclerosis (MS)…”
Get full text

The impact of smoking cessation on multiple sclerosis disease progression by Rodgers, Jeff, Friede, Tim, Vonberg, Frederick W, Constantinescu, Cris S, Coles, Alasdair, Chataway, Jeremy, Duddy, Martin, Emsley, Hedley, Ford, Helen, Fisniku, Leonora, Galea, Ian, Harrower, Timothy, Hobart, Jeremy, Huseyin, Huseyin, Kipps, Christopher M, Marta, Monica, McDonnell, Gavin V, McLean, Brendan, Pearson, Owen R, Rog, David, Schmierer, Klaus, Sharrack, Basil, Straukiene, Agne, Wilson, Heather C, Ford, David V, Middleton, Rod M, Nicholas, Richard

“…The negative impact of smoking in multiple sclerosis is well established; however, there is much less evidence as to whether smoking cessation is beneficial to…”
Get full text

TWO CONCURRENT PARANEOPLASTIC SYNDROMES-USING OCCAM'S RAZOR by Doshi, Anisha, Wells, Geoffrey, Bodi, Istvan, Barritt, Andrew, Fisniku, Leonora

“…A 58 year old lady presented with rapidly progressive symmetrical limb weakness over a few weeks. She had a background of WHO-B2 thymoma diagnosed in 2005 with…”
Get full text

PO117 Regional efficacy of fingolimod in multiple sclerosis by Bogdan, Iulia, Warren, Catherine, Koniotes, Anna, Ruffer, Giles, Newell, Bettina, Fisniku, Leonora, Bremner, Stephen, Gabel, Matt C, Rashid, Waqar

“…BackgroundFingolimod is approved in England as second-line treatment for highly active relapsing-remitting multiple sclerosis (RRMS).ObjectivesTo evaluate the…”
Get full text

Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐sectional analysis from the MS‐STAT2 randomized controlled trial by Williams, Thomas, John, Nevin, Calvi, Alberto, Bianchi, Alessia, De Angelis, Floriana, Doshi, Anisha, Wright, Sarah, Shatila, Madiha, Yiannakas, Marios C., Chowdhury, Fatima, Stutters, Jon, Ricciardi, Antonio, Prados, Ferran, MacManus, David, Braisher, Marie, Blackstone, James, Ciccarelli, Olga, Gandini Wheeler‐Kingshott, Claudia A. M., Barkhof, Frederik, Chataway, Jeremy, Brownlee, Wallace, Wynne, Megan, Hockey, Leanne, Parker, Josephine, Flight, Jennifer, Frost, Chris, Nicholas, Jennifer, Nixon, Stuart, Beveridge, Judy, Chandran, Siddharthan, Connick, Peter, Lyle, Dawn, Galea, Ian, Jarman, Elisabeth, Ford, Helen, Fernandes, Linford, Vinjam, Maruthi, Pavitt, Sue, Sharrack, Basil, Paling, David, Shehu, Abdullah, Arun, Tarunya, Belhag, Mohamed, Pearson, Owen, Ingram, Gillian, Rickards, Christopher, McDonnell, Gavin, Hughes, Stella, Spilker, Cord, Fisniku, Leonora, Aram, Julia, Rice, Claire, Pluchino, Stefano, Peruzzotti‐Jametti, Luca, Harikrishnan, Sreedharan, Guck, Nikki, Robertson, Neil, Tallantyre, Emma, Harrower, Timothy, Gallagher, Paul, Ahmed, Fayyaz, Young, Carolyn, Arndt, Heike, Silber, Eli, Nicholas, Richard, Duddy, Martin, Lee, Martin, Evangelou, Nikos, Allen, Christopher, Craner, Matthew, Geraldes, Ruth, Hobart, Jeremy, Hillier, Charles, Chhetri, Suresh, Mattoscio, Miriam, Chaudhuri, Abhijit, Kalra, Seema, Straukiene, Agne, Rog, David

“…Background and purpose There is increasing evidence that cardiovascular risk (CVR) contributes to disability progression in multiple sclerosis (MS). CVR is…”
Get full text

A study of referral bias in NMOSD and MOGAD cohorts by Leal Rato, Miguel, Chen, Bo, Francis, Anna, Messina, Silvia, Miron, Madalina, Sharawakanda, Yvonne, O'Sullivan, Eoin, Cooper, Sarah, Fisniku, Leonora, Halfpenny, Christopher, Martin, Roswell, Hobart, Jeremy, Rashid, Waqar, Hemingway, Cheryl, Williams, Victoria, Hacohen, Yael, Dobson, Ruth, Ramdas, Sithara, Leite, Maria Isabel, Palace, Jacqueline, Geraldes, Ruth

“…•Relapsing rate in MOGAD is overestimated in cohorts from specialised centres.•Clinical presentation does not differ across local, regional, or national…”
Get full text